🔗 Share this article

Treasury head Reeves has announced she is preparing "specific steps to address household expense pressures" in the forthcoming financial statement.

In comments to the BBC, she emphasized that curbing inflation is a collective responsibility of both the government and the Bank of England.

The United Kingdom's inflation rate is expected to be the highest among the G7 industrialized countries this calendar year and the following year.

Possible Energy Cost Interventions

Sources suggest the government could take action to lower energy bills, for instance by cutting the current 5% level of value-added tax charged on energy supplies.

An additional option is to lower some of the policy costs presently added to household expenses.

Budgetary Limitations and Expert Expectations

The administration will receive the latest assessment from the official forecaster, the Office for Budget Responsibility, on Monday, which will show how much scope there is for such actions.

The expectation from the majority of experts is that Reeves will have to declare tax increases or budget cuts in order to meet her declared fiscal targets.

Earlier on Thursday, estimates suggested there was a £22bn deficit for the chancellor to address, which is at the lower end of expectations.

"There's a joint job between the Bank of England and the administration to bear down further on some of the drivers of inflation," the Chancellor informed the BBC in the US capital, at the yearly gatherings of the International Monetary Fund and World Bank.

Tax Commitments and International Issues

While a great deal of the attention has been on likely tax rises, the chancellor said the latest figures from the fiscal watchdog had not changed her pledge to campaign commitments not to increase rates on earnings tax, sales tax or social security contributions.

She blamed an "uncertain world" with increasing geopolitical and commercial tensions for the Budget revenue measures, likely to be targeted on those "with the broadest shoulders."

Global Trade Disputes

Commenting on apprehensions about the UK's commercial links with the Asian nation she said: "Our security interests always are paramount."

Recent announcement by China to increase export controls on rare earths and other resources that are essential for advanced tech manufacturing led American leader the US President to threaten an further 100% tariff on imports from China, increasing the prospect of an full-scale commercial conflict between the two economic giants.

The American finance chief labeled the Chinese move "commercial pressure" and "a global supply chain power grab."

Inquired about accepting the US offer to join its dispute with China, the Chancellor said she was "deeply worried" by China's actions and encouraged the Chinese government "to avoid restrictions and limit trade."

She said the action was "harmful for the international commerce and causes additional obstacles."

"It is my opinion there are areas where we should challenge China, but there are also valuable chances to sell into China's economy, including financial services and other areas of the economic system. We've got to achieve that balance right."

The chancellor also confirmed she was working with other major economies "on our own essential resources plan, so that we are more independent."

Health Service Medicine Pricing and Funding

The Chancellor also recognized that the price the National Health Service spends on medicines could go up as a consequence of ongoing discussions with the Trump administration and its pharmaceutical firms, in return for reduced taxes and capital.

Some of the biggest global drug companies have said recently that they are either pausing or canceling investments in the UK, with several blaming the modest returns they are obtaining.

Last month, the Science Minister said the price the health service pays for medicines would have to increase to prevent companies and drug research funding departing from the UK.

The Chancellor stated to the BBC: "It has been observed as a result of the pricing regime, that clinical trials, recent pharmaceuticals have not been offered in the UK in the way that they are in other EU nations."

"The objective is to ensure that patients receiving care from the National Health Service are able to receive the finest critical treatments in the globe. And so we are looking at these issues, and... aiming to attract additional investment into Britain."